Jiang Jing-Si, Zhang Ying, Luo Ying, Ru Yi, Luo Yue, Fei Xiao-Ya, Song Jian-Kun, Ding Xiao-Jie, Zhang Zhan, Yang Dan, Yin Shuang-Yi, Zhang Hui-Ping, Liu Tai-Yi, Li Bin, Kuai Le
Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Institute of Dermatology, Shanghai Academy of Traditional Chinese Medicine, Shanghai, China.
Front Pharmacol. 2021 Nov 16;12:726158. doi: 10.3389/fphar.2021.726158. eCollection 2021.
Sheng-Ji Hua-Yu (SJHY) formula has been proved to reduce the severity of diabetic wound healing without significant adverse events in our previous clinical trials. However, based on multi-target characteristics, the regulatory network among herbs, ingredients, and hub genes remains to be elucidated. The current study aims to identify the biomarkers of the SJHY formula for the treatment of diabetic wound healing. First, a network of components and targets for the SJHY formula was constructed using network pharmacology. Second, the ClusterONE algorithm was used to build a modular network and identify hub genes along with kernel pathways. Third, we verified the kernel targets by molecular docking to select hub genes. In addition, the biomarkers of the SJHY formula were validated by animal experiments in a diabetic wound healing mice model. The results revealed that the SJHY formula downregulated the mRNA expression of , , and , while upregulated , , , and . Besides, the SJHY formula upregulated the kernel pathways, neuroactive ligand-receptor interaction, and cAMP signaling pathway in the skin tissue homogenate of the diabetic wound healing mice model. In summary, this study identified the potential targets and kernel pathways, providing additional evidence for the clinical application of the SJHY formula for the treatment of diabetic wound healing.
生肌化瘀(SJHY)方在我们之前的临床试验中已被证明可减轻糖尿病伤口愈合的严重程度,且无明显不良事件。然而,基于多靶点特性,草药、成分和枢纽基因之间的调控网络仍有待阐明。当前研究旨在确定SJHY方治疗糖尿病伤口愈合的生物标志物。首先,利用网络药理学构建SJHY方的成分与靶点网络。其次,使用ClusterONE算法构建模块化网络并识别枢纽基因以及核心通路。第三,通过分子对接验证核心靶点以选择枢纽基因。此外,在糖尿病伤口愈合小鼠模型中通过动物实验验证SJHY方的生物标志物。结果显示,SJHY方下调了 、 和 的mRNA表达,而上调了 、 、 和 。此外,SJHY方上调了糖尿病伤口愈合小鼠模型皮肤组织匀浆中的核心通路、神经活性配体-受体相互作用和cAMP信号通路。总之,本研究确定了潜在靶点和核心通路,为SJHY方治疗糖尿病伤口愈合的临床应用提供了更多证据。